Literature DB >> 32051785

Mini-Open Access for Lateral Lumbar Interbody Fusion: Indications, Technique, and Outcomes.

Stephan N Salzmann1, Gary A Fantini1, Ichiro Okano1, Andrew A Sama1, Alexander P Hughes1, Federico P Girardi1.   

Abstract

BACKGROUND: Lateral lumbar interbody fusion (LLIF) is a relatively new procedure. It was established as a minimally invasive alternative to traditional open interbody fusion. LLIF allows the surgeon to access the disc space via a retroperitoneal transpsoas muscle approach. Theoretical advantages of the LLIF technique include preservation of the longitudinal ligaments, augmentation of disc height with indirect decompression of neural elements, and insertion of large footprint cages spanning the dense apophyseal ring bilaterally1,2. The original 2-incision LLIF technique described by Ozgur et al., in 2006, had some inherent limitations3. First, it substantially limited direct visualization of the surgical field and may have endangered nerve and vascular structures. Additionally, it often required multiple separated incisions for multilevel pathologies. Finally, for surgeons with experience in traditional open retroperitoneal surgery, utilization of their previously acquired skills may have been difficult with this approach. To overcome these limitations, we adopted the mini-open lateral approach, which allows for visualization, palpation, and electrophysiologic neurologic confirmation during the procedure4. DESCRIPTION: As detailed below, the patient is positioned in the lateral decubitus position and a single incision is carried out centered between the target discs. For single-level LLIF, the incision spans approximately 3 cm and can be lengthened in small increments for multilevel procedures. After blunt dissection, the retroperitoneal space is entered. The psoas muscle is split under direct visualization, carefully avoiding the traversing nerves with neurosurveillance5. A self-retaining retractor is used, and after thorough discectomy, the disc space is sized with trial components. The implant is filled with bone graft materials and is introduced using intraoperative fluoroscopy. ALTERNATIVES: The 2-incision LLIF technique or traditional anterior or posterior lumbar spine interbody fusion techniques might be used instead. RATIONALE: LLIF offers the reported advantages of minimally invasive surgery, such as reduced tissue trauma during the approach, low blood loss, shorter length of stay, decreased recovery time, and less postoperative pain. LLIF allows for the placement of a relatively larger interbody cage spanning the dense apophyseal ring bilaterally. The lateral approach preserves the anterior longitudinal ligament and posterior longitudinal ligament. These structures allow for powerful ligamentotaxis and provide extra stability for the construct. Compared with other approaches, LLIF has a reduced risk of visceral and vascular injuries, incidental dural tears, and perioperative infections. Although associated with approach-related complications such as motor and sensory deficits, LLIF can be a safe and versatile procedure1,2.
Copyright © 2019 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Year:  2019        PMID: 32051785      PMCID: PMC6974316          DOI: 10.2106/JBJS.ST.19.00013

Source DB:  PubMed          Journal:  JBJS Essent Surg Tech        ISSN: 2160-2204


  19 in total

Review 1.  Lateral Lumbar Interbody Fusion: Indications, Outcomes, and Complications.

Authors:  Brian Kwon; David Hanwuk Kim
Journal:  J Am Acad Orthop Surg       Date:  2016-02       Impact factor: 3.020

2.  Aortic perforation during lateral lumbar interbody fusion.

Authors:  Alexander Aichmair; Gary A Fantini; Sean Garvin; James Beckman; Federico P Girardi
Journal:  J Spinal Disord Tech       Date:  2015-03

3.  An institutional six-year trend analysis of the neurological outcome after lateral lumbar interbody fusion: a 6-year trend analysis of a single institution.

Authors:  Alexander Aichmair; Marios G Lykissas; Federico P Girardi; Andrew A Sama; Darren R Lebl; Fadi Taher; Frank P Cammisa; Alexander P Hughes
Journal:  Spine (Phila Pa 1976)       Date:  2013-11-01       Impact factor: 3.468

4.  Access related complications during anterior exposure of the lumbar spine.

Authors:  Gary A Fantini; Abhijit Y Pawar
Journal:  World J Orthop       Date:  2013-01-18

5.  Nerve injury after lateral lumbar interbody fusion: a review of 919 treated levels with identification of risk factors.

Authors:  Marios G Lykissas; Alexander Aichmair; Alexander P Hughes; Andrew A Sama; Darren R Lebl; Fadi Taher; Jerry Y Du; Frank P Cammisa; Federico P Girardi
Journal:  Spine J       Date:  2013-09-05       Impact factor: 4.166

6.  Contralateral psoas hematoma after minimally invasive, lateral retroperitoneal transpsoas lumbar interbody fusion: a multicenter review of 3950 lumbar levels.

Authors:  Joshua M Beckman; Berney Vincent; Michael S Park; James B Billys; Robert E Isaacs; Luiz Pimenta; Juan S Uribe
Journal:  J Neurosurg Spine       Date:  2016-08-05

7.  The rising psoas sign: an analysis of preoperative imaging characteristics of aborted minimally invasive lateral interbody fusions at L4-5.

Authors:  Jean-Marc Voyadzis; Daniel Felbaum; Jay Rhee
Journal:  J Neurosurg Spine       Date:  2014-03-07

Review 8.  Lateral Lumbar Interbody Fusion-Outcomes and Complications.

Authors:  Stephan N Salzmann; Jennifer Shue; Alexander P Hughes
Journal:  Curr Rev Musculoskelet Med       Date:  2017-12

9.  Maintenance of Segmental Lordosis and Disk Height in Stand-alone and Instrumented Extreme Lateral Interbody Fusion (XLIF).

Authors:  Gregory M Malham; Ngaire J Ellis; Rhiannon M Parker; Carl M Blecher; Rohan White; Ben Goss; Kevin A Seex
Journal:  Clin Spine Surg       Date:  2017-03       Impact factor: 1.876

10.  Minimally Invasive Lateral Lumbar Interbody Fusion: Clinical and Radiographic Outcome at a Minimum 2-year Follow-up.

Authors:  Suhel Kotwal; Satoshi Kawaguchi; Darren Lebl; Alexander Hughes; Russel Huang; Andrew Sama; Frank Cammisa; Federico Girardi
Journal:  J Spinal Disord Tech       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.